A New Bronchiectasis Endophenotype: Immunoallertypes

por McShane, Pamela J.
Publicado 2019

A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf

por Chalmers, James D., Gupta, Abhya, Chotirmall, Sanjay H., Armstrong, April, Eickholz, Peter, Hasegawa, Naoki, McShane, Pamela J., O'Donnell, Anne E., Shteinberg, Michal, Watz, Henrik, Eleftheraki, Anastasia, Diefenbach, Claudia, Sauter, Wiebke
Publicado 2023

The 6-minute walk test predicts mortality in a pulmonary nontuberculous mycobacteria-predominant bronchiectasis cohort

por Blakney, Rebekah A., Ricotta, Emily E., Follmann, Dean, Drew, Jessica, Carey, Kelly A., Glass, Lisa N., Robinson, Chevalia, MacDonald, Sandra, McShane, Pamela J., Olivier, Kenneth N., Fennelly, Kevin, Prevots, D. Rebecca
Publicado 2022